Tumor necrosis factor‐α inhibitor‐induced follicular psoriasiform eruption

Tumor necrosis factor‐α inhibitor‐associated adverse cutaneous reactions are common in patients with inflammatory bowel disease. Infection‐related dermatoses and psoriasiform eruptions are seen most frequently. We describe a follicular psoriasiform eruption that appeared during treatment with inflix...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldberger, Tal, Benshushan, Stephanie, Davidovics, Zev, Wilschanski, Michael, Molho‐Pessach, Vered
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541162/
https://www.ncbi.nlm.nih.gov/pubmed/35466459
http://dx.doi.org/10.1111/pde.14993
Descripción
Sumario:Tumor necrosis factor‐α inhibitor‐associated adverse cutaneous reactions are common in patients with inflammatory bowel disease. Infection‐related dermatoses and psoriasiform eruptions are seen most frequently. We describe a follicular psoriasiform eruption that appeared during treatment with infliximab in two adolescents with Crohn's disease.

Ejemplares similares